Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Microfluidic platform for cancer Intravasation: pass or no pass?

Project description

Microfluidic platform to study the cancer intravasation process

Cancer is a leading cause of death due to metastasis. A key step in this process is intravasation, where cancer cells enter the bloodstream to form secondary tumours. The ERC-funded Intrap project aims to explore how mechanical factors influence this process, as preventing intravasation could stop cancer from spreading. It will investigate how mechanical cues affect intravasation. To do this, it will develop a microfluidic platform with multi-chip models of blood vessels and extracellular matrices to study intravasation. Using live microscopy, the project aims to gain insights into cancer metastasis, potentially informing the development of treatment strategies.

Objective

Cancer still is one of the world’s deadliest diseases. Most devastating is the ability of cancer cells to spread throughout the body in a multistep process called metastasis, the major cause for mortality. A critical step is intravasation, when cancer cells pass a blood vessel wall to enter the blood stream, and travel to another location to create a secondary tumor. However, the mechanisms of intravasation are still largely unexplored, even though it is pivotal: if we can prevent it, cancer does not spread. Intrap aims to enhance our understanding of intravasation through a unique experimental approach.
We hypothesize that intravasation is critically controlled by mechanical cues like stiffness, geometry, and adhesive interactions; after all, the act of passing the vessel wall requires mechanical action of the cells: deforming, adhering, detaching, moving, and overcoming mechanical forces. We will take a systematic approach enabling to separately control different mechanical cues, and directly observe their effect on intravasation. The groundbreaking result will be a pass-no-pass phase diagram that shows under which conditions cancer cells can or cannot pass a vessel wall.
We will develop an innovative microfluidic platform with a multi-chip architecture for in vitro intravasation testing. In the individual chips we will create blood vessels with varying geometry and permeability, surrounded by extracellular matrices with pre-determined mechanical properties in which different tumor cells or cell clusters with known or controlled mechanical properties will be integrated. We will directly observe the intravasation process using live microscopy.
Our platform will open new approaches to cancer research; our discoveries will expand our scientific knowledge of metastasis. Beyond Intrap, the obtained insights can contribute to the development of highly needed novel cancer treatments that intervene with mechanical properties of cancer cells, matrix or blood vessels.

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-ERC - HORIZON ERC Grants

See all projects funded under this funding scheme

Call for proposal

(opens in new window) ERC-2024-ADG

See all projects funded under this call

Host institution

TECHNISCHE UNIVERSITEIT EINDHOVEN
Net EU contribution
€ 3 123 287,00
Address
GROENE LOPER 3
5612 AE Eindhoven
Netherlands
Region
Zuid-Nederland Noord-Brabant Zuidoost-Noord-Brabant
Activity type
Higher or Secondary Education Establishments
Links
Total cost
No data

Beneficiaries (1)